Fingerprint
Dive into the research topics of 'CXCR2 antagonist MK-7123 a phase 2 proof-of-concept trial for chronic obstructive pulmonary disease'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
CXCR2 antagonist MK-7123 a phase 2 proof-of-concept trial for chronic obstructive pulmonary disease
Stephen I. Rennard, David C. Dale, James F. Donohue, Frank Kanniess, Helgo Magnussen, E. Rand Sutherland, Henrik Watz, Susan Lu, Paul Stryszak, Elizabeth Rosenberg, Heribert Staudinger
Research output: Contribution to journal › Article › peer-review
166
Scopus
citations